Non‐anti‐D antibodies in red‐cell alloimmunization

G Lobo, L. Nardozza, Luiz Camano

International Journal of Gynecology & Obstetrics · 2006 · 13 citations · 2 references

Concepts

Abstract

Red-cell alloimmunization is an immune disorder due to an incompatibility between maternal and fetal red blood cell antigens [1]. Because of its high prevalence and immunogenicity, antigen-D incompatibility is the most frequent cause of red-cell alloimmunization. However, red blood cells have more than 400 other surface antigens, at least 43 of which being capable of producing hemolytic disease [2]. The following antigens are frequently associated with perinatal hemolytic disease: Rh (D, C, E, c, e, f, Cw); Kell (K, k-celano, Kpa, Kpb, Jsa, Jsb); MNS (M, N, s, S); Kidd (JKa, JKb); Duffy (Fya, Fyb); and Lutheran [3]. This observational descriptive study compared the perinatal outcomes of non-anti-D alloimmunized and anti-D alloimmunized pregnancies with those of a control group. The entire study population, which consisted of 200 patients managed over 5 years, comprised 15 non-D alloimmunized patients (group 1) and 55 Rh-negative alloimmunized (group 2). The following variables were analyzed: sonographic findings, indirect Coombs test results, need for intrauterine transfusion, mode of delivery, gestational age at birth, neonatal transfusion, mean neonatal hematocrit, duration of neonatal hospitalization, and perinatal mortality. The findings for groups 1 and 2 are shown in Table 1. The relative frequency of non-D alloimmunized patients has been rising in the last decades. A large study involving over 18,000 pregnant women [3] reported the frequency of irregular antibodies to be 1.62% (299 cases) in this population. In the present study there were 7 patients with antibodies against the Lewis system. These maternal antibodies do not cause hemolytic disease because they are mainly IgM antibodies. The rate of intrauterine transfusion was similar in both study groups although there was 1 case of transfusion in group 1, in a patient sensitized to a Kell antigen (K). Several publications have described cases of anti-Kell-alloimmunized pregnancies resulting in adverse perinatal outcomes. There was 1 perinatal death in group 1, but it was unrelated to hemolysis since it occurred in the offspring of a woman with anti-Lewis antibodies who had a child with muscular dystrophy. Apart from Rh sensitization, there are no specific strategies for the prevention of non-D alloimmunization. Labor management in these patients should follow general recommendations, such as avoiding an excessive use of oxytocin, performing amniotomy at the proper time, maintaining the woman upright, avoiding manual removal of the placenta and uterine massage, and unclamping the umbilical cord while awaiting placental detachment.

References

2